Terms: = Sarcomas AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
58 results:
1. treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
[TBL] [Abstract] [Full Text] [Related]
2. The Effects of Fucoidan Derived from
Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
[TBL] [Abstract] [Full Text] [Related]
3. Risk Factors for treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
[No Abstract] [Full Text] [Related]
4. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
[TBL] [Abstract] [Full Text] [Related]
5. [Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].
Yan Q; Yao WT; Du XH; Guo LY; Fan YC
Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):904-910. PubMed ID: 37875427
[No Abstract] [Full Text] [Related]
6. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
[TBL] [Abstract] [Full Text] [Related]
7. The FBXO32/atr/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
[TBL] [Abstract] [Full Text] [Related]
8. Synergistic anticancer activity of combined atr and ribonucleotide reductase inhibition in Ewing's sarcoma cells.
Sturm MJ; Henao-Restrepo JA; Becker S; Proquitté H; Beck JF; Sonnemann J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8605-8617. PubMed ID: 37097390
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study.
Özdemir B; Gerçeker GÖ; Özdemir EZ; Yildirim BG; Ören H; Yiş U; Günay Ç; Thomas GÖ
J Pediatr Nurs; 2023; 72():185-190. PubMed ID: 37076371
[TBL] [Abstract] [Full Text] [Related]
10. Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract] [Full Text] [Related]
11. Amputation surgery associated with shortened survival in patients with localized soft tissue sarcoma.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Hishimura R; Suzuki Y; Hamasaki M; Iwata A; Kondo E; Iwasaki N
J Orthop Sci; 2024 Mar; 29(2):637-645. PubMed ID: 36931976
[TBL] [Abstract] [Full Text] [Related]
12. Sarcoma brain metastases: Tertiary cancer center experience.
Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
[TBL] [Abstract] [Full Text] [Related]
13. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (atr) kinase inhibitor.
Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD
Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930
[TBL] [Abstract] [Full Text] [Related]
14. Elimusertib (BAY1895344), a novel atr inhibitor, demonstrates in vivo activity in atrX mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic targeting of atr in alveolar rhabdomyosarcoma.
Dorado García H; Pusch F; Bei Y; von Stebut J; Ibáñez G; Guillan K; Imami K; Gürgen D; Rolff J; Helmsauer K; Meyer-Liesener S; Timme N; Bardinet V; Chamorro González R; MacArthur IC; Chen CY; Schulz J; Wengner AM; Furth C; Lala B; Eggert A; Seifert G; Hundsoerfer P; Kirchner M; Mertins P; Selbach M; Lissat A; Dubois F; Horst D; Schulte JH; Spuler S; You D; Dela Cruz F; Kung AL; Haase K; DiVirgilio M; Scheer M; Ortiz MV; Henssen AG
Nat Commun; 2022 Jul; 13(1):4297. PubMed ID: 35879366
[TBL] [Abstract] [Full Text] [Related]
16. Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells.
Malakoti F; Majidinia M; Ahmadi Y; Yousefi B; Shanebandi D
Drug Res (Stuttg); 2022 Sep; 72(7):378-384. PubMed ID: 35724673
[TBL] [Abstract] [Full Text] [Related]
17. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
[TBL] [Abstract] [Full Text] [Related]
18. FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles.
Perut F; Graziani G; Roncuzzi L; Zini N; Avnet S; Baldini N
Cells; 2022 Feb; 11(5):. PubMed ID: 35269400
[TBL] [Abstract] [Full Text] [Related]
19. A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil.
de Figueiredo LO; Júnior AAG; de Assis Acurcio F; Almeida AM; Cherchiglia ML; Wainstein AJA; Thuler LCS; Nogueira-Rodrigues A
Sci Rep; 2021 Nov; 11(1):22501. PubMed ID: 34795383
[TBL] [Abstract] [Full Text] [Related]
20. Ouabain Induces DNA Damage in Human Osteosarcoma U-2 OS Cells and Alters the Expression of DNA Damage and DNA Repair-associated Proteins.
Yang JL; Yang MD; Chen JC; Lu KW; Huang YP; Peng SF; Chueh FS; Liu KC; Lin TS; Chen PY; Chen WJ
In Vivo; 2021; 35(5):2687-2696. PubMed ID: 34410957
[TBL] [Abstract] [Full Text] [Related]
[Next]
